Yes and the only satisfaction we may have is if the buyer markets Recaf instead of putting it on the back shelf somewhere.I would be completely satisfied,if BOCX sold everything but the rapid test and the new patent for combining recaf with other radioactive agents or compounds to fight cancer.Used the money to pay off debt and bring along the rapid test and Recaf as a therapeutic compound drug.
News 
Market Data 
Discover 
